ArticleDiagnostics (Basel, Switzerland)2026
Clinicopathological Features, Tumor Localization and Treatment Outcomes in Paraganglioma: A Single-Center Medical Oncology Cohort.
Hatice Asoglu, Esra Asarkaya, Abdurrahman Aykut, Gunes Dorukhan Cavusoglu, Yasemin Aydinalp Camadan, Irem Kolsuz Turker, Hacer Demirkose, Tolga Koseci, Ertugrul Bayram, Gamze Akkus and 3 more
Abstract read
In one paragraphArticle in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Hatice AsogluDepartment of Medical Oncology, Faculty of Medicine, Çukurova University, Adana 01330, Türkiye.ORCID 0009-0000-1366-5552 Esra AsarkayaDepartment of Medical Oncology, Faculty of Medicine, Çukurova University, Adana 01330, Türkiye.
Abdurrahman AykutDepartment of Medical Oncology, Faculty of Medicine, Çukurova University, Adana 01330, Türkiye.ORCID 0000-0002-2671-9393 Gunes Dorukhan CavusogluDepartment of Medical Oncology, Faculty of Medicine, Çukurova University, Adana 01330, Türkiye.ORCID 0000-0001-8914-7911 Yasemin Aydinalp CamadanDepartment of Medical Oncology, Şanlıurfa Mehmet Akif İnan Education and Research Hospital, Şanlıurfa 63300, Türkiye.ORCID 0000-0003-2435-368X Irem Kolsuz TurkerDepartment of Endocrinology, Faculty of Medicine, Çukurova University, Adana 01330, Türkiye.
Hacer DemirkoseDepartment of Communicable Diseases and Early Warning, General Directorate of Public Health, Ministry of Health, Ankara 06430, Türkiye.
Tolga KoseciDepartment of Medical Oncology, Faculty of Medicine, Çukurova University, Adana 01330, Türkiye.
Ertugrul BayramDepartment of Medical Oncology, Faculty of Medicine, Çukurova University, Adana 01330, Türkiye.ORCID 0000-0001-8713-7613 Gamze AkkusDepartment of Endocrinology, Faculty of Medicine, Çukurova University, Adana 01330, Türkiye.
Ramazan AsogluDepartment of Cardiology, Yalova State Hospital, Yalova Provincial Health Directorate, Yalova 77200, Türkiye.ORCID 0000-0002-4777-1166 Seyda ErdoganDepartment of Pathology, Faculty of Medicine, Çukurova University, Adana 01330, Türkiye.
Ismail Oguz KaraDepartment of Medical Oncology, Faculty of Medicine, Çukurova University, Adana 01330, Türkiye.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
GAPPKi-67medical oncologyparagangliomapeptide receptor radionuclide therapyprognosisrecurrence-free survivaltumor localization
Identifiers
PMID42650918
PMCPMC13512060
What OpenQuestion holds
Textmetadata
Read underepoch 390